4.3 Article

Downregulation of NKG2DLs by TGF-β in human lung cancer cells

Journal

BMC IMMUNOLOGY
Volume 22, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12865-021-00434-8

Keywords

NKG2D ligands; Transforming growth factor beta; Matrix metalloproteinase

Categories

Funding

  1. Financial Supporting Project of Long-term Overseas Dispatch of PNU's Tenure-track Faculty, 2016
  2. National Research Foundation of Korea (NRF) - Korea government, Ministry of Science and ICT (MSIT) [NRF-2018R1D1A1B07047437]

Ask authors/readers for more resources

In this study, it was found that TGF-beta reduced the surface protein levels of five NKG2DLs in lung cancer cells without altering transcription levels. Galunisertib reversed this effect of TGF-beta on NKG2DLs expression.
BackgroundTransforming growth factor beta (TGF-beta) is a typical immuno-inhibitory cytokine and highly secreted by lung cancer cells. It was supposed that its immunosuppressive effects to NK cell might be related with the altered expression of activating and inhibitory molecules in lung cancer cells. In this study, we examined the expression of NKG2DLs, PD-L1 and PD-L2 in lung cancer cells after treatment of TGF-beta and a TGF-beta inhibitor, Galunisertib (LY2157299).ResultsTGF-beta reduced the level of surface proteins of five NKG2DLs without altered transcription levels in lung cancer cells. Galunisertib reversed the effect of TGF-beta on the expression of NKG2DLs. Since MMP inhibitors, MMPi III and MMP2 inhibitor I, restored the reduced expression of NKG2DLs after treatment of TGF-beta, it was thought that TGF-beta induced the expression of MMP2 which facilitated the shedding of the NKG2DLs in cancer cells. However, the expression of PD-L1, L2 were not changed by treatment with TGF-beta or Galunisertib.ConclusionsTherefore, inhibition of TGF-beta might reverse the immunosuppressive status on immune cells and restore NK cell mediated anticancer immune responses by upregulation of NKG2DLs in cancer cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available